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Abstract
Background: Staphylococcus aureus is a well-armed pathogen prevalent in severe infections such as endocarditis
and osteomyelitis. Fibronectin-binding proteins A and B, encoded by fnbA/B, are major pathogenesis determinants
in these infections through their involvement in S. aureus adhesion to and invasion of host cells. Sub-minimum
inhibitory concentrations (sub-MICs) of antibiotics, frequently occurring in vivo because of impaired drug diffusion
at the infection site, can alter S. aureus phenotype. We therefore investigated their impact on S. aureus fibronectin-
mediated adhesiveness and invasiveness.
Methods: After in vitro challenge of S. aureus 8325-4 and clinical isolates with sub-MICs of major anti-
staphylococcal agents, we explored fnbA/B transcription levels, bacterial adhesiveness to immobilised human
fibronectin and human osteoblasts in culture, and bacterial invasion of human osteoblasts.
Results: Oxacillin, moxifloxacin and linezolid led to the development of a hyper-adhesive phenotype in the
fibronectin adhesion assay that was consistent with an increase in fnbA/B transcription. Conversely, rifampin
treatment decreased fibronectin binding in all strains tested without affecting fnbA/B transcription. Gentamicin and
vancomycin had no impact on fibronectin binding or fnbA/B transcription levels. Only oxacillin-treated S. aureus
displayed a significantly increased adhesion to cultured osteoblasts, but its invasiveness did not differ from that of
untreated controls.
Conclusion: Our findings demonstrate that several antibiotics at sub-MICs modulate fibronectin binding in S.
aureus in a drug-specific fashion. However, hyper- and hypo- adhesive phenotypes observed in controlled in vitro
conditions were not fully confirmed in whole cell infection assays. The relevance of adhesion modulation during in
vivo infections is thus still uncertain and requires further investigations.
Background
Staphylococcus aureus is a prevalent and dangerous
pathogen in humans, causing a wide range of infections.
The initial step of suppurative infections, such as infec-
tive endocarditis or osteomyelitis, involves bacterial adhe-
sion to the extracellular matrix and cell surface of the
host. Several microbial factors involved in this adherence
are present in S. aureus [1]. Among these factors, collec-
tively designated as microbial surface components recog-
nising adhesive matrix molecules (MSCRAMMs),
fibronectin-binding proteins A and B (FnBPA/B) play a
major role in S. aureus pathogenicity through their ability
to bind fibronectin and fibrinogen and to initiate integ-
rin-mediated intracellular uptake of the bacteria by non-
professional phagocytes such as endothelial cells or
osteoblasts [2,3]. The invasion of host cells by S. aureus
eventually leads to the formation of an intracytoplasmic
reservoir, where bacteria remain protected from the
action of cell- and antibody-mediated immune response
and from that of most antimicrobial agents. This bacter-
ial sanctuarisation makes successful treatment even more
challenging and paves the way for infection relapse [4].
* Correspondence: oana.dumitrescu@chu-lyon.fr
1INSERM, U851, Lyon 69008, France
Full list of author information is available at the end of the article
Rasigade et al. BMC Microbiology 2011, 11:263
http://www.biomedcentral.com/1471-2180/11/263
© 2011 Rasigade et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.A peculiar difficulty to be faced in treating deep-seated
infections is the risk of impaired diffusion of antimicrobial
agents at the infection site, where they would only achieve
sub-inhibitory concentrations. S. aureus strains challenged
with such antibiotic concentrations have been shown to
exhibit altered phenotypes depending on the molecule
tested, including down- or up-regulation of virulence fac-
tor expression. For example, beta-lactams enhance the
secretion of virulence factors such as the Panton-Valentine
leukocidin and alpha haemolysin, while clindamycin or
linezolid exert an inhibitory effect [5-8]. However, most
studies on the antibiotic-mediated modulation of protein
expression by S. aureus have focused on secreted exotox-
ins, and less is known about this modulation with respect
to MSCRAMMS, including FnBPA/B.
In the present study, we aimed to investigate the impact
of sub-inhibitory concentrations of major anti-staphylo-
coccal agents on the adhesion and invasion phenotypes of
S. aureus.A f t e rin vitro challenge of S. aureus reference
strain 8325-4 and clinical isolates with antibiotics, we
explored the following: (i) mRNA expression levels of the
fnbAa n dfnbB genes, which encode FnBPA and B, respec-
tively; (ii) bacterial adhesiveness to immobilised human
fibronectin and human osteoblasts in culture; and (iii) bac-
terial invasion of human osteoblasts.
Methods
Bacterial strains
The bacterial strains used in this study are summarised in
Table 1. Laboratory strain 8325-4 and its ΔfnbA/B deriva-
tive DU5883 were used as a control for fnbA/B [9]. Clini-
cal isolates were characterised for the presence of the
fnbA, fnbB, agr1-4 and mecA genes by PCR as previously
described [10,11], and MLST was performed as described
by Enright et al. to identify their genetic background [12].
Antibiotics and MIC determination
The antibiotics used in this study were as follows: oxacil-
lin, gentamicin, clindamycin, rifampicin and vancomycin
purchased from Sigma-Aldrich (L’Isle d’Abeau, France);
linezolid provided by Pfizer (Amboise, France); and moxi-
floxacin provided by Bayer (Wuppertal, Germany). Mini-
mal inhibitory concentrations were determined by broth
microdilution assay as recommended by the Clinical
Laboratory Standards Institute (CLSI) standards [13].
Bacterial cultures
The strains were cultured on trypticase blood agar plates
and incubated overnight at 37°C. Isolated colonies were
resuspended in 5 ml brain heart infusion (BHI) in glass
tubes (AES Chemunex France) and adjusted to 0.5 McFar-
land turbidity, corresponding to 10
8 CFU/ml, as confirmed
by bacterial count. Bacterial suspensions were cultivated at
37°C with 300 rpm gyratory shaking. After 1 h, antibiotics
were added to the culture medium at a concentration of
half the MIC, and the incubation was continued for 2
additional hours to reach the mid-exponential phase.
McFarland turbidity was measured at the end of the incu-
bation step to determine the impact of antibiotics treat-
ment on bacterial density. Aliquots were then taken, and
cellular pellets were prepared as described below for total
RNA extraction, the microplate adhesion assay, and the
whole cell adhesion and invasion assay.
Relative quantitative RT-PCR
Aliquots of 1 mL of the S. aureus 8325-4 cultures were
centrifuged at 13,000 g, and the pellets were washed
w i t h1m Lo f1 0m MT r i sb u f f e ra n da d j u s t e dt oa n
optical density at 600 nm (OD600) of 1, corresponding
to approximately 1 × 10
9 S. aureus cells/mL. One mL of
adjusted and washed bacterial suspension was centri-
fuged at 13,000 g, and the pellets were treated with
lysostaphin (Sigma-Aldrich) at a final concentration of
200 mg/L. The total RNA of the pellets was then puri-
fied using the RNeasy Plus Mini Kit (Qiagen) according
to the manufacturer’s instructions. The RNA yield was
assessed by UV absorbance, and 1 microgram of total
RNA was reverse transcribed using the Reverse Tran-
scription System (Promega) with random primers, as
recommended by the provider. The resulting cDNA was
used as the template for real-time amplification of gyrB,
fnbAa n dfnbB using specific primers (Table 2). The
relative amounts of the fnbAa n dfnbB amplicons were
determined by quantitative PCR relative to a gyrB inter-
nal standard, as described elsewhere [14]. The calibra-
tors in our study were the transcripts from the S. aureus
8325-4 strain grown without antibiotics, normalised with
respect to gyrB transcription level. gyrB expression was
not modified by sub-inhibitory antibiotics, thus allowing
its use as an internal control. The relative fold changes
in the fnbAa n dfnbB expression levels were calculated
using the 2
-ΔΔCt method using the RealQuant software
(Roche Diagnostics).
Table 1 Characterisation of bacterial strains used in this
study
Strain Type fnbA fnbB mecA agr ST
a
8325-4 laboratory strain + + - 1 8
DU 5883 8325-4 ΔfnbA/B [9] - - - 1 8
ST2008
1028
clinical isolate,
osteomyelitis
++ -3 3 0
ST2008
0563
clinical isolate,
osteomyelitis
++ -1 8
HT2001
0390
clinical isolate,
endocarditis
++ -3 1
HT2001
0594
clinical isolate,
endocarditis
++ -2 1 5
aSequence Type (ST) was determined as described by Enright et al. [12]
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Flat-bottom 96-well plates (Immuno Nunc) were coated
with 50 μg/mL plasma human fibronectin (Sigma-
Aldrich) and incubated overnight at 4°C. Coated plates
were inoculated with 200 μL per well of bovine serum
albumin BSA and incubated for 20 min at 37°C, and
then each well was washed 3 times.
Aliquots of the bacterial cultures described above were
centrifuged at 13,000 g for 10 min, and the cellular pel-
lets were washed and resuspended in PBS (Dulbecco’s
Phosphate Buffered Saline, Sigma-Aldrich). Bacterial sus-
pensions were adjusted to an OD600 of 1, corresponding
to approximately 1 × 10
9 S. aureus cells/mL. One hun-
dred μL of each bacterial suspension was incubated in 3
different wells of the fibronectin-coated plate for 45 min
at 37°C with mild shaking. Each well was washed 3 times
with PBS to remove non-adherent bacteria. Adherent
bacteria were fixed with glutaraldehyde (2.5% v/v in 0.1
mol/L PBS) for 2 h at 4°C and then stained with crystal
violet (0.1% m/v) for 30 min at room temperature. Excess
stain was rinsed off with Triton X100 solution (0.2% v/v,
H2O), and the plates were dried at room temperature.
Bacterial adhesion to fibronectin was assessed spectro-
photometrically (Spectrophotometer MR5000, Dynatec)
by determining the optical density at 570 nm (OD570).
The results were expressed as the mean ± standard devia-
tion based on triplicates. To assess the potential con-
founding role of antibiotics-induced reduction of
bacterial density in our model, we also searched for a
correlation between n-fold changes in bacterial densities
and fibronectin binding levels in antibiotics-treated strain
8325-4, as compared to the untreated control.
Cell culture
All cell culture reagents were purchased from GIBCO
(Paisley, UK). The human osteoblastic cell line MG-63
(LGC Standards, Teddington, UK) was grown in Dul-
becco’s modified Eagle medium (DMEM) containing 2
mM L-glutamine and 25 mM HEPES, 10% foetal bovine
serum (FBS) and 100 U/mL penicillin and streptomycin
(culture medium) at 37°C and 5% CO2.C e l l sw e r es u b -
cultured twice a week and used up to passage 10 after
thawing.
Adhesion and invasion assay with human osteoblasts
MG-63 cells were seeded at 50,000 cells/well in 24-well
plates and incubated at 37°C with 5% CO2 for 48 h in
culture medium. S. aureus strain 8325-4 was treated with
sub-inhibitory concentrations of oxacillin, linezolid or
rifampicin as described above and then washed and
resuspended in antibiotic-free culture medium. The
untreated S. aureus strain DU5883 (isogenic mutant of
strain 8325-4 deleted for the genes fnbA/B) was used as a
negative control. MG-63 cells were washed twice with
DMEM and were infected with bacterial suspensions at a
multiplicity of infection of approximately 50:1, as con-
firmed by bacterial count. Cells were incubated for 2 h at
37°C to allow for adhesion and internalisation of the bac-
teria and then washed twice with DMEM to remove
unbound bacteria. For the adhesion assay, cells were ana-
lysed using osmotic shock in pure water and extensively
pipetted to achieve full release of cell-associated bacteria.
For the invasion assay, infected cells were further incu-
bated for 1 h in culture medium containing 200 mg/L
gentamicin to kill extracellular bacteria but not interna-
lised bacteria. Cells were then washed twice in DMEM
and analysed as described above to release internalised
bacteria. For both the adhesion and invasion assays,
viable bacteria in cell lysates were enumerated by plate
counting on agar. The number of adherent bacteria was
calculated by subtracting the number of internalised bac-
teria from the number of total cell-associated bacteria.
The results were expressed as the mean ± standard devia-
tion of the percentage of recovered internalised or adher-
ent bacteria with respect to inoculated bacteria, derived
from four independent experiments performed in
duplicate.
Statistical analysis
The statistical analyses were based on the use of one-
way ANOVA followed by the a posteriori Dunnett’s test.
Correlation analysis was performed using Spearman’s
rank correlation coefficient. The level of statistical sig-
nificance was set at 0.05. The tests were carried out
with SPSS for Windows version 12.0 software.
Results
Susceptibility to antibiotics of bacterial strains cultured in
BHI
We first examined the influence of the experimental con-
ditions on the MIC values of tested strains. The oxacillin,
gentamicin, vancomycin, clindamycin, linezolid, moxi-
floxacin and rifampin MICs were determined using CLSI
recommendations and compared to those obtained with
BHI inoculated with 5 × 10
5 CFU/mL (Table 3). MICs in
BHI were of the same magnitude as those obtained in
Mueller-Hinton, therefore we used BHI medium for the
rest of this study.
Table 2 Primers used for qRT-PCR in this study
Primer name 5’ 3’ sequence Reference
gyrB F GGTGGCGACTTTGATCTAGC [14]
gyrB R TTATACAACGGTGGCTGTGC [14]
fnbA F ATTGAGACATTTAATAAAGCGA [15]
fnbA R TTTTGAATAATCGGACCATT [15]
fnbB F CACCGAAAACTGTGCAAGCA [16]
fnbB R TTCCTGTAGTTTCCTTATCAGCAACTT [16]
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coated microplates
We determined the influence of antibiotics on the adhe-
sion of S. aureus to fibronectin using a fibronectin-coated
microplate adhesion assay. We tested standardised bacter-
ial suspensions of 6 strains previously cultured without
antibiotics or with 1/2 MIC oxacillin, gentamicin, vanco-
mycin, clindamycin, linezolid, rifampicin or moxifloxacin.
As shown in Figure 1, the adhesion to fibronectin was dif-
ferentially modulated by the antibiotics. Oxacillin-, moxi-
floxacin-, clindamycin- and linezolid-treated bacteria
displayed increased binding to fibronectin. This effect was
observed for all strains tested except fnbA/B-negative
DU5883. The increase in amplitude of fibronectin binding
was strain-dependent. Oxacillin treatment increased fibro-
nectin binding from 1.8- to 2.7-fold relative to the
untreated control; moxifloxacin treatment increased bind-
ing from 1.4- to 2.3-fold; clindamycin treatment increased
binding from 1.5- to 1.8-fold; and linezolid treatment
increased binding from 1.6- to 2.3-fold, depending on the
tested strain. By contrast, fibronectin binding was signifi-
cantly reduced after rifampicin treatment. The decrease
was strain-dependent and ranged from 1.5- to 3.5-fold
compared to the untreated control. Vancomycin and gen-
tamicin had no effect on bacterial adhesion to fibronectin-
coated plates (data not shown). Antibiotics-induced reduc-
tion in bacterial density had no significant confounding
effect on fibronectin binding in our model, as demon-
strated by the absence of correlation between n-fold
changes in bacterial density and fibronectin binding in
antibiotics-treated strain 8325-4 (Additional File 1). The
DU5883 strain, defective for fnbA and fnbB genes [9], did
not adhere to fibronectin-coated plates in any condition
(with or without antibiotics). Clindamycin could not be
tested with the DU5883 strain as it harbours the ermB
gene and therefore is resistant to clindamycin (Table 3).
Effect of antibiotics on fnbA and fnbB mRNA levels
We explored the effect of antibiotics on mRNA expres-
sion levels of the fnbAa n dfnbB genes which encode
FnBPA/B. The fnbA and fnbB mRNA levels in exponen-
tial phase cultures of S. aureus 8325-4, grown with 1/2
MIC oxacillin, gentamicin, vancomycin, clindamycin,
linezolid, rifampicin or moxifloxacin, were compared to
those in an untreated culture and expressed as n-fold
variation. A change in mRNA level was interpreted as
significant if there was greater than 2-fold variation. As
shown in Figure 2, oxacillin induced a 5.5-fold increase
in the fnbAm R N Al e v e la n d8 . 5 - f o l di n c r e a s ei nt h e
fnbB mRNA level; moxifloxacin induced a 2.7-fold
increase in the fnbA mRNA level and 4.5-fold increase
in the fnbB mRNA level; and linezolid induced a 3.8-
fold increase in the fnbA mRNA level and 6.5-fold
increase in the fnbB mRNA level. No significant changes
in fibronectin binding gene expression were observed
for gentamicin, vancomycin, clindamycin or rifampicin.
Effect of antibiotics on the adhesion and invasion of
osteoblastic cells
We investigated whether antibiotic-mediated modulation
of the expression of fnbAa n dfnbB induced changes in
S. aureus adhesion to and invasion of host cells in an ex
vivo model. We infected osteoblastic MG-63 cells with
the following: (i) S. aureus 8325-4, either untreated or
treated with 1/2 MIC linezolid, oxacillin or rifampicin
and (ii) invasion-deficient strain DU5883. We then com-
pared the amounts of adherent and internalised bacteria
recovered after 2 h. As shown in Figure 3, oxacillin-trea-
ted S. aureus exhibited significantly increased adhesion
(682 ± 374%) compared to untreated S. aureus (256 ±
128%), whereas the adhesion of bacteria treated with line-
zolid or rifampicin (279 ± 141% and 306 ± 190%, respec-
tively) did not differ significantly from the untreated
control. Strain DU5883 showed a tendency towards
impaired adhesion (151 ± 40%) compared to its parental
strain 8325-4. With respect to bacterial invasion, bacteria
treated with linezolid, oxacillin or rifampicin (6.7 ± 4.9%,
9.2 ± 4.1% and 10.4 ± 7.8%, respectively) did not exhibit
significant differences compared to the untreated control
Table 3 MICs of antibiotics tested in BHI medium against 6 selected S. aureus strains
MIC (mg/L) in BHI medium
a
Antibiotic 8325-4 DU5883 ST2008 1028 ST2008 0563 HT2000 0594 HT2001 0390
Oxacilllin 0.25 0.25 0.25 0.25 0.25 0.25
Gentamicin 1 1 1 1 1 1
Vancomycin 2 2 1 1 2 2
Clindamycin 0.15 > 128
b 0.30 0.30 0.30 0.30
Linezolid 1 1 1 1 1 1
Rifampicin 0.006 0.006 0.006 0.006 0.006 0.006
Moxifloxacin 0.12 0.12 0.12 0.12 0.12 0.12
aMICs were determined with a standard microdilution method recommended by the CSLI in BHI medium inoculated with 5 × 10
5 CFU/mL
bDU5883 strain is
resistant to clindamycin as it harbours the ermB gene [9]
Rasigade et al. BMC Microbiology 2011, 11:263
http://www.biomedcentral.com/1471-2180/11/263
Page 4 of 9(6.0 ± 5.1%), while host cell invasion was abolished in
strain DU5883 lacking fnbA and fnbB (0.0 ± 0.0%).
Discussion
Several major findings emerge from this investigation of
the impact of sub-inhibitory concentrations of anti-staphy-
lococcal drugs on S. aureus adhesion and invasion pheno-
types. S. aureus binding to human fibronectin and the
transcriptional levels of the fnbA/B genes encoding the
fibronectin-binding proteins were differentially modulated
by antimicrobial agents. Oxacillin, moxifloxacin and line-
zolid treatment led to the development of a hyper-adhe-
sive phenotype, along with an increase in fnbA/B mRNA
levels relative to the gyrB internal standard. The same
hyper-adhesive phenotype was induced by clindamycin
treatment, although no significant change in fnbA/B
mRNA levels was observed. Rifampin was the only antimi-
crobial agent among those tested that significantly inhib-
ited S. aureus binding to fibronectin without affecting
relative fnbA/B transcription profiles. Vancomycin and
gentamicin induced no change in either the adhesion phe-
notype or the fnbA/B transcription. S. aureus adhesion to
and invasion of live eukaryotic cells was also assessed after
oxacillin, linezolid or rifampin treatment in an ex vivo
infection model of cultured human osteoblasts. Oxacillin
treatment significantly increased S. aureus adhesion but
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Figure 1 Effect of antibiotics on the adhesion to human fibronectin. Exponential growth cultures of S. aureus laboratory strains 8325-4 and
DU5883 and clinical isolates ST2008 1028, ST2008 0563, HT2000 0594 and HT2001 0390 were treated or not treated with 1/2 of the MIC of
antibiotics (oxacillin, moxifloxacin, clindamycin, linezolid or rifampicin) and assayed for adhesion to fibronectin-coated microplates, as described
in Methods section. The results are OD570 nm values reflecting bacterial adhesion to fibronectin. The values were obtained from 3 different
wells previously incubated with the same bacterial suspension, and adhesion is expressed as the mean ± standard deviation (dark bars for
untreated cultures and white bars for antibiotic treated cultures; results from three different experiments). Asterisk = significantly different from
the control (corresponding isolate grown without antibiotic), with a P value of 0.05 by one-way analysis of variance followed by a posteriori
Dunnett’s test.
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Figure 2 Effect of antibiotics on fnbAa n dfnbBm R N Al e v e l s . Exponentially growing cultures of S. aureus 8325-4 were treated for 2 h with
no antibiotics or with 1/2 the MIC of oxacillin, gentamicin, vancomycin, moxifloxacin, clindamycin, linezolid or rifampicin. Samples of each
culture were taken and adjusted to an OD600 of 1 and then used for total RNA extraction and subsequent reverse transcription with random
primers, as described above. The cDNA obtained was used as the template for LightCycler PCR with specific fnbA, fnbB and gyrB primers.
Relative quantification was performed by reporting it relative to gyrB expression, as described elsewhere [14]. The results are expressed as the n-
fold variation of fnbA( white bars) and fnbB( black bars) mRNA levels in the presence of each antibiotic relative to the growth of no antibiotic
control levels. The values are the means ± standard deviations (four different experiments). A change in mRNA level was interpreted as
significant if greater than 2-fold variation.
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Figure 3 Effect of antibiotics on S. aureus adhesion to and invasion of human osteoblasts. MG-63 osteoblastic cells were infected for 2 h
at approximately 50 bacteria/cell with S. aureus strain 8325-4, pre-treated or not (untreated control) with 1/2 MIC linezolid, oxacillin or rifampicin,
and S. aureus strain DU5883 lacking fnbA and fnbB (negative control). To enumerate cell-associated bacteria, infected cells were washed twice to
discard unbound bacteria and analysed by osmotic shock in pure water, and then, suitable dilutions of the lysates were plated on agar. The
same procedure was used to quantify intracellular bacteria, except that the cells were incubated for 1 h with 200 mg/L gentamicin before the
lysis step to kill extracellular bacteria. Adherent bacteria were calculated by subtracting intracellular bacteria from cell-associated bacteria. The
results were expressed as the means +/- standard deviation of the percentage of recovered internalised (a) or adherent (b) bacteria with respect
to inoculated bacteria derived from four independent experiments performed in duplicate. Asterisk = significantly different from the control
(corresponding isolate grown without antibiotic), with a P value of 0.05 by one-way analysis of variance followed by a posteriori Dunnett’s test.
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Page 6 of 9not invasion, while no significant change in adhesion or
invasion levels was observed after linezolid or rifampin
treatment.
Several recent studies have focused on the influences of
sub-inhibitory concentrations of antimicrobial agents on
the expression of various virulence factors produced by S.
aureus and on the various regulation mechanisms involved
in this modulation [6,8,17]. Similarly, the expression and
surface display of FnBPs are regulated by a complex net-
work of global regulators and stress response pathways
that can be triggered by antimicrobial agents in a drug-
specific fashion. Fluoroquinolones, by activating the SOS
system (a global response system to DNA damage), have
been shown to induce fnbB up-regulation and fibronectin
binding in S. aureus through a LexA-RecA-dependant
pathway [18]. Moreover, in a rabbit S. aureus infection
model, moxifloxacin treatment inhibited the expression of
agr global regulator [19], which acts as a repressor of sur-
face protein expression, including fnbA/B, and as an acti-
vator of exotoxin expression [20]. Beta-lactams, besides
inducing the SOS response system [21], have also been
reported to up-regulate virulence factor expression,
including fnbB, through the two-component system SaeRS
[22].
Clindamycin and linezolid are protein synthesis inhibi-
tory agents known to repress exotoxin secretion by
S. aureus [6-8]. Thus, their positive effect on fibronectin
binding in S. aureus makes it tempting to speculate that
their impact on protein expression involves selective
inhibition of agr. We recently showed that sub-inhibitory
concentrations of linezolid repress early agr expression in
S. aureus [23]. Furthermore, sub-inhibitory concentra-
tions of clindamycin have been shown to decrease saeRS
expression [24], thus possibly interfering with fnbB
expression. An alternative explanation for the effects of
clindamycin has been reported by Blickwede et al., who
observed that fnbB mRNA levels were selectively
increased after clindamycin treatment and that this
increase was due to mRNA stabilisation in the presence
of clindamycin [25]. Whether linezolid also affects fnbA/
B mRNA levels through mRNA stabilisation remains
unknown, and this question merits further investigations.
With respect to sub-inhibitory rifampin treatment, the
decrease in fibronectin binding observed here was not
accompanied by a transcriptional decrease of fnbA/B
relative to the internal control gyrB, suggesting that fibro-
nectin binding inhibition takes place at the post-tran-
scriptional level. Mechanisms underlying the effects of
rifampin in this context are still to be elucidated. We
speculate that these mechanisms could involve either a
decrease of sortase activity, which is responsible for cell
wall anchorage of several MSCRAMMs including FnBPs
[26,27], or an increase of protease activity, which has
been shown to dramatically influence fibronectin-binding
in S. aureus [28].
Interestingly, fibronectin-binding modulation by oxacil-
lin, linezolid or rifampin only partially correlated with host
cell adhesion and invasion under our experimental condi-
tions. Although oxacillin-treated S. aureus displayed signif-
icantly increased binding to cultured osteoblasts, its
invasiveness did not differ significantly from that of the
untreated control. Beta-lactams interfere with cell division
and induce dramatic changes in staphylococcal morphol-
ogy even at sub-inhibitory concentrations [29]. Of note,
the inhibition of cell separation ultimately leads to the for-
mation of so-called pseudomulticellular staphylococci [30].
These aberrant forms were present following oxacillin
treatment under our experimental conditions, whereas
bacterial size and morphology were unchanged in bacteria
either untreated or treated with rifampin or linezolid, as
objectivated by microscopic examination after fluores-
cence staining of the cell wall (data not shown). It is likely
that the larger size of pseudomulticellular staphylococci
hampers their internalization by osteoblasts, which could
negatively compensate the increase in adhesiveness
induced by oxacillin. In the same way, we failed to identify
a change in adhesion and invasion phenotypes after linezo-
lid or rifampin treatment. A putative explanation for these
discrepancies between phenotypes observed under both
controlled in vitro conditions and more complex ex vivo
infection assays is adhesin redundancy. Although FnBPs
play a major role in S. aureus-host cell interactions, whole
cell adhesion involves several other MSCRAMMs [31],
which are also likely regulated by antibiotics and thus
could hamper or cancel the effects of FnBPs modulation.
This outcome is illustrated by our finding that strain
DU5883 lacking fnbA/B still adhered significantly to cul-
tured osteoblasts. The same is probably true with respect
to S. aureus invasiveness, although a more limited number
of factors are involved along with FnBPs in the cell inva-
sion process. FnBPs are required and sufficient for host
cell invasion [27], as confirmed in our model by the obser-
vation that invasiveness was abolished in strain DU5883.
However, the multifunctional protein eap, which also
binds fibronectin, acts additively with FnBPs to mediate
host cell invasion in eap-positive strains such as 8325-4
[32] and can partially compensate for loss of FnBP func-
tions [27]. Additional studies are warranted to determine
whether compensatory mechanisms occur to sustain host
cell invasion, despite rifampin-mediated FnBP expression
decrease.
Conclusions
It has long been well-established that the choice of anti-
microbial agents in therapy should not solely rely on
their respective bactericidal or bacteriostatic activity and
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influence on bacterial virulence [33,34], including adhe-
sion phenotype. Our results confirm that several anti-
staphylococcal agents induce a hyper-adhesive phenotype
in S. aureus through FnBP up-regulation in vitro, while
only rifampin inhibits fibronectin binding. However,
drug-dependent modulation of adhesion, although unam-
biguous at the molecular and specific ligand-binding
level, was not always significant in our ex vivo model.
This paradoxical observation is reminiscent of that
recently reported by Ythier et al., who demonstrated that
in vitro adherence to fibronectin of clinical S. aureus iso-
lates did not correlate with infectivity in a rat model of
endocarditis [35]. While antibiotic-mediated modulation
of secreted exotoxins has proved fully relevant in the
clinical field with respect to several toxin-associated dis-
eases [33,34], the relevance of adhesion modulation dur-
ing in vivo infections is still uncertain and requires
further investigation.
Additional material
Additional file 1: Impact of antibiotics on the growth kinetics of S.
aureus strain 8325-4 and correlation analysis between n-fold
changes in bacterial density and fibronectin binding. Panel A.
Bacterial suspensions were cultivated with or without antibiotics at half-
MIC for 2 h as described above. Growth curves with and without
antibiotics are represented as Δ log variations of the bacterial density.
Panel B. Antibiotics-treated suspensions of S. aureus 8325-4 were assayed
for fibronectin binding as described above. Spearman’s rank correlation
coefficient was calculated and no correlation was found between the
bacterial density changes and fibronectin binding measures.
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